Antilipidemic Drug Therapy Today and in the Future
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/164_2015_15
Reference256 articles.
1. Aicher TD, Boyd SA, McVean M, Celeste A (2010) Novel therapeutics and targets for the treatment of diabetes. Exp Rev Clin Pharmacol 3:209–229
2. Akdim F, Visser ME, Tribble DL, Baker BF, Stroes ES, Yu R et al (2010) Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia. Am J Cardiol 105:1413–1419
3. Alexander V, Gaudet D, Cheng W, Flaim J, Hughes S, Singleton W et al (2014) An antisense inhibitor of apolipoprotein C-III significantly decreases apolipoprotein C-III, triglycerides, very-low-density lipoprotein cholesterol and particle number, and increases high-density lipoprotein cholesterol and particle number in hypertriglyceridemic patients on fibrate. J Am Coll Cardiol 63(112):A1453, Abstract A1453
4. Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, Platt R (1995) Discontinuation of antihyperlipidemic drugs—do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 332:1125–1131
5. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, SHARP Investigators et al (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 377:2181–2192
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prophylactic and therapeutic potential of active phytoconstituents from Amomum subulatum Roxb;Food Frontiers;2022-11-23
2. Bempedoic Acid and the Fraudulent Fatty Acid Family: The Gold Rush to Cardiovascular Therapies in the New Millennium;Organic Process Research & Development;2021-03-05
3. Bioactive Algal-Derived Polysaccharides: Multi-Functionalization, Therapeutic Potential and Biomedical Applications;Current Pharmaceutical Design;2019-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3